Validity of IGFBP-1, 2, 3 genes expression IGFBP-1, 2, 3 for discrimination between studied groups (control vs CML cases) and (Resistant vs Sensitive cases). This evidence concerns the gene IGFBP1 and chronic myelogenous leukemia, BCR-ABL1 positive.